Cognex (NASDAQ:CGNX) Posts Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Cognex (NASDAQ:CGNX) posted its quarterly earnings data on Wednesday. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.09, FiscalAI reports. Cognex had a net margin of 13.62% and a return on equity of 10.86%. The company had revenue of $268.44 million for the quarter, compared to the consensus estimate of $245.98 million. During the same quarter in the previous year, the firm posted $0.14 EPS. The business’s revenue was up 24.3% compared to the same quarter last year. Cognex updated its Q2 2026 guidance to 0.400-0.440 EPS.

Cognex Price Performance

CGNX opened at $66.13 on Friday. The company has a market cap of $11.04 billion, a price-to-earnings ratio of 78.72 and a beta of 1.48. The firm has a 50 day simple moving average of $52.67 and a 200 day simple moving average of $45.20. Cognex has a fifty-two week low of $28.56 and a fifty-two week high of $71.90.

Cognex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st will be paid a $0.085 dividend. The ex-dividend date of this dividend is Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. Cognex’s payout ratio is currently 40.48%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on CGNX. Raymond James Financial restated a “strong-buy” rating on shares of Cognex in a report on Thursday, February 12th. Stephens lifted their target price on shares of Cognex from $65.00 to $75.00 and gave the company an “overweight” rating in a research report on Thursday. Barclays lifted their target price on shares of Cognex from $61.00 to $64.00 and gave the company an “overweight” rating in a research report on Monday, March 16th. DA Davidson set a $55.00 target price on shares of Cognex and gave the company a “neutral” rating in a research report on Tuesday, February 17th. Finally, KeyCorp reiterated an “overweight” rating and set a $70.00 target price (up from $50.00) on shares of Cognex in a research report on Friday, February 13th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $62.29.

Insider Buying and Selling

In related news, VP Laura Ann Macdonald sold 14,881 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $57.16, for a total transaction of $850,597.96. Following the completion of the sale, the vice president directly owned 2,212 shares of the company’s stock, valued at $126,437.92. The trade was a 87.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Robert Willett sold 177,052 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $58.39, for a total transaction of $10,338,066.28. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 196,083 shares of company stock valued at $11,419,321 over the last ninety days. Insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On Cognex

A number of institutional investors and hedge funds have recently modified their holdings of the business. Pacer Advisors Inc. raised its stake in shares of Cognex by 18.2% during the fourth quarter. Pacer Advisors Inc. now owns 26,562 shares of the scientific and technical instruments company’s stock worth $956,000 after buying an additional 4,084 shares during the last quarter. Virtu Financial LLC bought a new stake in Cognex in the fourth quarter valued at approximately $379,000. Invesco Ltd. increased its stake in Cognex by 9.6% in the fourth quarter. Invesco Ltd. now owns 401,487 shares of the scientific and technical instruments company’s stock valued at $14,446,000 after purchasing an additional 35,230 shares in the last quarter. Corient Private Wealth LLC increased its stake in Cognex by 77.3% in the fourth quarter. Corient Private Wealth LLC now owns 57,009 shares of the scientific and technical instruments company’s stock valued at $2,058,000 after purchasing an additional 24,854 shares in the last quarter. Finally, Front Street Capital Management Inc. increased its stake in Cognex by 1.1% in the fourth quarter. Front Street Capital Management Inc. now owns 1,309,295 shares of the scientific and technical instruments company’s stock valued at $47,108,000 after purchasing an additional 14,306 shares in the last quarter. 88.12% of the stock is owned by institutional investors.

Key Cognex News

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Q1 results and upbeat Q2 guide — Cognex reported revenue of $268M (+24% YoY) and EPS $0.34, topping estimates, and issued Q2 revenue guidance of $280–$300M with EPS $0.40–$0.44, signaling continued growth and margin leverage. Cognex Reports First Quarter 2026 Results
• Positive Sentiment: Margin and profitability beat — gross margin expanded to ~71% and adjusted EBITDA margin improved materially, underscoring operating leverage that supports higher EPS power. Cognex Q1 Earnings and Revenues Top Estimates
• Positive Sentiment: AI product momentum highlighted on the call — management emphasized AI-led vision product launches and demand across broad end markets, which investors view as a durable growth driver. Cognex Earnings Call Highlights AI-Led Profit Surge
• Positive Sentiment: Analyst price-target upgrade — Stephens raised its price target to $75 and moved to overweight, giving formal Street support that can drive buy-side flows. Cognex Given New $75.00 Price Target at Stephens
• Positive Sentiment: Unusually heavy call activity — a large block of call option volume suggests short-term bullish positioning by traders/speculators ahead of/after the results. Cognex Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Dividend announced — Cognex declared a $0.085 quarterly dividend (annualized ~0.5% yield), a modest income signal but not a material catalyst for stock rerating. Listen to Conference Call / Press Release
• Neutral Sentiment: Market commentary and stock momentum pieces question valuation after a big run — some articles debate whether further upside is warranted after substantial YTD/one‑year gains; useful for investor context but not new company data. Is It Too Late To Consider Cognex (CGNX) After A 121% One Year Surge?
• Negative Sentiment: Recent insider selling and some institutional repositioning — public filings referenced notable insider sales and large portfolio moves that could weigh on sentiment if sustained. Cognex shares jump on Q1 beat and upbeat Q2 outlook

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.